When It Comes to Ketamine, Meta’s Posting Policy Is No Party to Decipher
Despite growing awareness that the party drug is dangerous, the social media company is open to promotion of the drug in treating mental health.
Showing 21 - 40 of 50
-
-
Hacking at UnitedHealth Unit Cripples a Swath of the US Health System: What to Know
Change Healthcare, a firm recently bought by insurance giant UnitedHealth Group, reportedly suffered a cyberattack. The company processes 14 billion transactions annually, including payments and requests for insurance authorizations.
By Darius Tahir -
‘Behind the Times’: Washington Tries to Catch Up With AI’s Use in Health Care
Lawmakers and regulators are trying to understand how AI is changing health care and how it should be regulated. The industry fears overreach.
By Darius Tahir -
-
When a Quick Telehealth Visit Yields Multiple Surprises Beyond a Big Bill
For the patient, it was a quick and inexpensive virtual appointment. Why it cost 10 times what she expected became a mystery.
By Darius Tahir -
GOP Presidential Hopefuls Use Trump’s Covid Record to Court Vaccine Skeptics
Candidates see former President Donald Trump’s embrace of his administration’s covid-19 vaccine policies as an opportunity to gain ground. So far, their efforts haven’t found traction.
By Darius Tahir and Daniel Chang -
Progressive and Anti-Abortion? New Group Plays Fast and Loose to Make Points
Progressive Anti-Abortion Uprising, which operates mostly in the nation’s capital, is part of a confrontational anti-abortion movement that embraces all types of media — graffiti, social media, and livestreams — to communicate a smashmouth message.
By Darius Tahir -
-
Few Firm Beliefs and Low Trust: Americans Not Sure What’s True in Age of Health Misinformation
A new poll from KFF shows many Americans aren’t willing to embrace misinformation — but aren’t willing to reject it either. And they don’t know whom to trust.
By Darius Tahir -
The NIH Ices a Research Project. Is It Self-Censorship?
The National Institutes of Health appeared to be digging into health misinformation. But then the federal agency stepped back. It can’t quite explain why, sometimes even offering contradictory explanations.
By Darius Tahir -
FDA Head Robert Califf Battles Misinformation — Sometimes With Fuzzy Facts
FDA Commissioner Robert Califf has called misinformation one of the deadliest killers in the United States. As the FDA tries to fight that scourge, it sometimes stumbles.
By Darius Tahir -
How a Combination of Covid Lawsuits and Media Coverage Keeps Misinformation Churning
Even as the covid-19 pandemic wanes, litigation — whether about vaccines, masks, or a range of other public health policies made during the pandemic — isn’t about to end.
By Darius Tahir -
Need to Get Plan B or an HIV Test Online? Facebook May Know About It
Twelve of the largest drugstores in the U.S. sent shoppers’ sensitive health information to Facebook or other platforms, according to an investigation by The Markup and KFF Health News.
-
Tech Luminaries Give RFK Jr.’s Anti-Vaccine Message a Boost
The views of the leader of a broad anti-vaccine movement who is now running for president are unchallenged in public forums run by several prominent Silicon Valley figures.
By Darius Tahir -
How the Mixed Messaging of Vaccine Skeptics Sows Seeds of Doubt
Some GOP members of the House Select Subcommittee on the Coronavirus Pandemic have two-stepped around vaccine skepticism, proclaiming themselves to be pro-vaccine while also validating the beliefs of people who oppose vaccine mandates. The result could have serious public health consequences.
By Darius Tahir -
AI May Be on Its Way to Your Doctor’s Office, But It’s Not Ready to See Patients
Giant corporations like Microsoft and Google, plus many startups, are eyeing health care profits from programs based on artificial intelligence.
By Darius Tahir -
Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
By Darius Tahir and Hannah Norman -
Mark Cuban Has Been Taking On the Drug Industry. But Which One?
The billionaire entrepreneur and NBA team owner is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.
By Darius Tahir -
Postcard From San Francisco
The Biggest, Buzziest Conference for Health Care Investors Convenes Amid Fears the Bubble Will Burst
This year’s JPMorgan confab, the first since covid’s chilling effect on such gatherings, was full of energy and enthusiasm. But it was also marked by questions about the future of health care investment.
By Darius Tahir -
Behavioral Telehealth Loses Momentum Without a Regulatory Boost
As flexible treatment options spurred by the covid pandemic wane, patients relying on medications classified as controlled substances worry that without action to extend the loosened rules, it’ll be harder to get their meds.
By Darius Tahir
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: